Compare LUNG & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNG | BYND |
|---|---|---|
| Founded | 1995 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 231.6M |
| IPO Year | 2020 | 2018 |
| Metric | LUNG | BYND |
|---|---|---|
| Price | $2.11 | $11.21 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 7 |
| Target Price | ★ $5.38 | $0.83 |
| AVG Volume (30 Days) | 465.3K | ★ 18.4M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.64 | ★ 24.69 |
| EPS | N/A | ★ N/A |
| Revenue | $90,497,000.00 | ★ $275,496,000.00 |
| Revenue This Year | $2.48 | N/A |
| Revenue Next Year | $18.46 | $1.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $1.13 | $0.40 |
| 52 Week High | $2.89 | $15.47 |
| Indicator | LUNG | BYND |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 60.44 |
| Support Level | $1.20 | $0.65 |
| Resistance Level | $2.16 | $15.47 |
| Average True Range (ATR) | 0.15 | 0.92 |
| MACD | -0.06 | -0.56 |
| Stochastic Oscillator | 2.88 | 4.06 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.